Given its role in predicting CD8+ cell infiltration and overall survival, the PD-L1 mRNA level might have potential as a biomarker to predict the efficiency of ICIs in MSS CRC; however, further work is needed to test this predictive value of PD-L1 mRNA in clinical practice. The gene discussed is CD274; the disease is colorectal carcinoma.